Increased Prevalence of Renal and Urinary Tract Anomalies in Children With Down Syndrome

Divisions of Pediatric Nephrology and Hypertension, Maimonides Infants and Children's Hospital, Brooklyn, New York 11219, USA.
PEDIATRICS (Impact Factor: 5.3). 09/2009; 124(4):e615-21. DOI: 10.1542/peds.2009-0181
Source: PubMed

ABSTRACT The goal was to investigate the prevalence of renal and urinary tract anomalies (RUTAs) in a Down syndrome (DS) population.
Data were obtained from the New York State Congenital Malformation Registry (NYS-CMR) in this retrospective cohort study. The occurrence of RUTAs was assessed for children with and without DS who were born in NYS between 1992 and 2004. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for each malformation.
Between 1992 and 2004, 3832 children with DS and 3 411 833 without DS were born in NYS. The prevalence of RUTAs in the DS population was 3.2%, compared with 0.7% in the NYS population (OR: 4.5 [95% CI: 3.8 -5.4]). Children with DS had significantly increased risks of anterior urethral obstruction (OR: 29.7 [95% CI: 4.0 -217.7]), cystic dysplastic kidney (OR: 4.5 [95% CI: 1.5-14.1]), hydronephrosis (OR: 8.7 [95% CI: 6.8 -11.0]), hydroureter (OR: 8.5 [95% CI: 3.5-20.4]), hypospadias (OR: 2.0 [95% CI: 1.4 -2.9]), posterior urethral valves (OR: 7.1 [95% CI: 1.8 -28.8]), prune belly syndrome (OR: 11.9 [95% CI: 1.6 - 85.4]), and renal agenesis (OR: 5.4 [95% CI: 2.8 -10.4]). There was no significantly increased risk of ectopic kidney (OR: 1.6 [95% CI: 0.2-11.2]) or ureteropelvic junction obstruction (OR: 1.4 [95% CI: 0.2-9.9]) in the DS population.
Children with DS have significantly increased risks of RUTAs.

  • [Show abstract] [Hide abstract]
    ABSTRACT: With increasingly effective medical interventions for congenital heart disease and leukemia, more individuals with Down syndrome (DS) are living into adulthood and old age. To enable children and adults with DS to be healthy and able to function well and live life fully, we need to be knowledgeable about the plethora of medical problems that are possible. In individuals with DS, each system has the potential of some or several types of medical problems that may require constant surveillance such as celiac disease or monitoring such as thyroid disease. These disorders may be more prevalent at different ages, such as arthropathy of DS, or constantly a potential issue, such as atlantoaxial subluxation. This chapter describes by system the multitude of potential medical problems that individuals with DS have an increased chance of developing at different ages.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite the fact that functional lower urinary tract symptoms are common among people with Down syndrome (DS), their voiding function has not been studied precisely. Our goal was to assess the lower urinary tract functions in DS. Fifty-five DS children aged 5 to 15 years old and 35 age-matched control children were evaluated by ultrasonography and uroflowmetry. Eleven (20%) DS children had no uresiesthesia, 21 (38%) were urinated under guidance, 9 (16%) urinated less than three times a day, 2 (4%) urinated more than ten times a day, 3 (5%) used diaper, and 26 (47%) had urinary incontinence. Seven (13%), 15 (27%), and 10 (18%) DS children had weak, prolonged and intermittent urination, respectively, and 7 (13%) had urination with straining. In contrast, none of the control subjects had urinary problems. In the uroflowmetrical analysis, 10 (18%), 20 (37%), 11 (20%) and 5 (9%) DS children showed "bell-shaped", "plateau", "staccato" and "interrupted" patterns, respectively; the remaining 9 (16%) could not be analyzed. In contrast, 21 (60%), one (3%), 4 (11%), 3(9%) and 2(6%) control subjects showed "bell-shaped", "tower-shaped", "plateau", "staccato" and "interrupted" patterns, respectively; the remaining 4 (11%) could not be analyzed. Residual urine was demonstrated in 4 (7%) DS and 1 (3%) control children. Lower urinary tract symptoms and abnormal uroflowmetry findings, which can lead to further progressive renal and urinary disorders, are common in DS children. Therefore, lower urinary tract functions should be assessed at the life-long regular medical checkups for subjects with DS.
    Pediatrics International 04/2014; 56(6). DOI:10.1111/ped.12367 · 0.73 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Atherosclerosis, one of the main causes of cardiovascular diseases, is a complex process that involves manifold factors. Besides the vascular lipids accumulation, inflammatory factors could be considered as a proatherogenic factor – RCAN1. RCAN1 is a regulator of calcineurin, both of them being calcium dependent proteins. Recent studies have shown that RCAN1 has an important role in heart valve development. In the same time researchers found that, the atherosclerotic plaques have an up-regulated RCAN1 gene expression. In the near future, it is desirable to elucidate the RCAN1 function and classify it as a possible biochemical marker to diagnose infancy atherosclerosis. Abbreviations: RCAN1 = regulator of calcineurin, LDL = low density lipoproteins, HMG-CoA – 3 = hydroxy-3-methylglutaryl coenzyme A, VSMCs = vascular smooth muscle cells, PDGF = platelet-derived growth factor, FGF = fibroblast growth factor, EGF = epidermal growth factor, IGF = insulin-like growth factor, VEGF = vascular endothelial growth factor, NFAT = nuclear factor of activated T cells, IL-2, IL-6, IL-10, IL-12 = interleukin type 2, 6, 10, 12, AP-1 = activator protein 1, Mef-2 = myocyte enhancer factor-2, GATA-4 = transcription factor, CK1 = casein kinase 1, GSK3 = glycogen synthase kinase 3, DYRK = dual specificity tyrosine phosphorylation regulated kinase, DSCR1 = Down Syndrome Critical Region 1, MCIP1 = myocyte-enriched calcineurin-interacting protein, MLP = muscle lim protein, cAMP = cyclic adenosine monophosphate, PC12 = pheochromocytoma, NMR = nuclear magnetic resonance, SOD = superoxide dismutase, APP = amyloid precursor protein, eNOS = nitric oxide endothelial synthase, Cygb = cytoglobin, HUVEC = human umbilical vein endothelial cells, VDR = vitamin D receptor
    Journal of medicine and life 10/2014; 7(4):481-487.